deoxycytidine and Appetite Disorders

deoxycytidine has been researched along with Appetite Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrams, RA; Blazeby, JM; Bridges, S; Bridgewater, J; Crosby, T; Dutton, P; Falk, S; Griffiths, G; Hurt, CN; Johnson, C; Joseph, G; Maughan, T; McDonald, A; Mukherjee, S; Staffurth, J1
Fukushi, K; Hashimoto, Y; Hatakeyama, S; Koie, T; Narita, T; Ohyama, C; Tobisawa, Y; Yamamoto, H; Yoneyama, T1

Trials

1 trial(s) available for deoxycytidine and Appetite Disorders

ArticleYear
Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer.
    International journal of radiation oncology, biology, physics, 2015, Nov-15, Volume: 93, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Deoxycytidine; Drug Administration Schedule; Fatigue; Feeding and Eating Disorders; Female; Follow-Up Studies; Gastrointestinal Diseases; Gemcitabine; Health Status; Humans; Induction Chemotherapy; Male; Pancreatic Neoplasms; Quality of Life; Statistics, Nonparametric; Surveys and Questionnaires; United Kingdom

2015

Other Studies

1 other study(ies) available for deoxycytidine and Appetite Disorders

ArticleYear
Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.
    International journal of urology : official journal of the Japanese Urological Association, 2017, Volume: 24, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Constipation; Deoxycytidine; Diarrhea; Feeding and Eating Disorders; Female; Gemcitabine; Humans; Male; Nausea; Patient Reported Outcome Measures; Prospective Studies; Quality of Life; Retrospective Studies; Treatment Outcome; Urologic Neoplasms

2017